Skip to main content
Journal cover image

The case against independent monitoring committees.

Publication ,  Journal Article
Harrington, D; Crowley, J; George, SL; Pajak, T; Redmond, C; Wieand, S
Published in: Stat Med
July 15, 1994

Duke Scholars

Published In

Stat Med

DOI

ISSN

0277-6715

Publication Date

July 15, 1994

Volume

13

Issue

13-14

Start / End Page

1411 / 1414

Location

England

Related Subject Headings

  • Treatment Outcome
  • Survival Analysis
  • Statistics & Probability
  • Reproducibility of Results
  • Randomized Controlled Trials as Topic
  • Neoplasms
  • Humans
  • Follow-Up Studies
  • Data Interpretation, Statistical
  • Clinical Trials, Phase III as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Harrington, D., Crowley, J., George, S. L., Pajak, T., Redmond, C., & Wieand, S. (1994). The case against independent monitoring committees. Stat Med, 13(13–14), 1411–1414. https://doi.org/10.1002/sim.4780131316
Harrington, D., J. Crowley, S. L. George, T. Pajak, C. Redmond, and S. Wieand. “The case against independent monitoring committees.Stat Med 13, no. 13–14 (July 15, 1994): 1411–14. https://doi.org/10.1002/sim.4780131316.
Harrington D, Crowley J, George SL, Pajak T, Redmond C, Wieand S. The case against independent monitoring committees. Stat Med. 1994 Jul 15;13(13–14):1411–4.
Harrington, D., et al. “The case against independent monitoring committees.Stat Med, vol. 13, no. 13–14, July 1994, pp. 1411–14. Pubmed, doi:10.1002/sim.4780131316.
Harrington D, Crowley J, George SL, Pajak T, Redmond C, Wieand S. The case against independent monitoring committees. Stat Med. 1994 Jul 15;13(13–14):1411–1414.
Journal cover image

Published In

Stat Med

DOI

ISSN

0277-6715

Publication Date

July 15, 1994

Volume

13

Issue

13-14

Start / End Page

1411 / 1414

Location

England

Related Subject Headings

  • Treatment Outcome
  • Survival Analysis
  • Statistics & Probability
  • Reproducibility of Results
  • Randomized Controlled Trials as Topic
  • Neoplasms
  • Humans
  • Follow-Up Studies
  • Data Interpretation, Statistical
  • Clinical Trials, Phase III as Topic